וולטרן אמפולות 75 מ"ג/3 מ"ל
novartis pharma services ag - diclofenac sodium 75 mg / 3 ml - solution for injection - diclofenac - intramuscular injectiontreatment of: - exacerbations of inflammatory and degenerative forms of rheumatism: rheumatoid arthritis, ankylosing spondylitis, osteoarthritis, spondylarthritis, non-articular rheumatism.- treatment of painful conditions due to inflammation of non rheumatic origin.- renal colic and biliary colic - post-traumatic and post-operative pain, inflammation and swelling
ארדיה 30 מ"ג
novartis pharma services ag - pamidronate disodium 30 mg/vial - powder for solution for infusion - pamidronic acid - treatment of: tumor induced hypercalcaemia, bone metastases and multiple myeloma. for the treatment of paget's disease of bone.
זומרה 4 מ"ג אבקה להזרקה
novartis pharma services ag - zoledronic acid 4 mg/vial - powder for solution for infusion - zoledronic acid - treatment of hypercalcaemia of malignancy. treatment of patients with multiple myeloma and patients with documented bone metastases from solid tumors, in conjunction with standard antineoplastic therapy. prostate cancer should have progressed after treatment with at least one hormonal therapy.
זומרה ® 4 מ"ג/5 מ"ל
novartis pharma services ag - zoledronic acid 4 mg/vial - concentrate for solution for infusion - zoledronic acid - treatment of hypercalcaemia of malignancy. treatment of patients with multiple myeloma and patients with documented bone metastases from solid tumors , in conjunction with standard antineoplastic therapy. prostate cancer should have progressed after treatment with at least one hormonal therapy.
קומטן ®
novartis pharma services ag - entacapone 200 mg - film coated tablets - entacapone - entacapone is indicated as an adjunct to standard preparations of levodopa/benserazide or levodopa/carbidopa for use in patients with parkinson`s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.
לפונקס 25 מ"ג טבליות
novartis pharma services ag - clozapine 25 mg - tablets - clozapine - treatment of resistant schizophrenic patients who are non-responsive to, or intolerant of classic neuroleptics. reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder who are judged to be at chronic risk for re-experiencing suicidal behavior, based on history and recent clinical state. suicidal behavior refers to actions by a patient that put him/herself at risk for death.
טופרניל 25 מ"ג טבליות
novartis pharma services ag - imipramine hydrochloride 25 mg - tablets - imipramine - treatment of various types of depression. in children and adolescents there is not sufficient evidence of safety and efficacy of tofranil in the treatment of all forms of depression. the use of tofranil in children and adolescents ( 0 - 17 years of age) in these indications is therefore not recommended.
ריטלין la ® 40 מ"ג כמוסות בשחרור מושהה
novartis pharma services ag - methylphenidate hydrochloride 40 mg - modified release capsules - methylphenidate - attention deficit hyperactivity disorder (adhd).
ריטלין la ® 30 מ"ג כמוסות בשחרור מושהה
novartis pharma services ag - methylphenidate hydrochloride 30 mg - capsules - methylphenidate - attention deficit hyperactivity disorder (adhd).
ריטלין la ® 20 מ"ג כמוסות בשחרור מושהה
novartis pharma services ag - methylphenidate hydrochloride 20 mg - capsules - methylphenidate - attention deficit hyperactivity disorder (adhd).